repetitive nerve stimulation and neuromuscular junction disorders
/ RNS /
Between the nerve and the muscle lies a tiny chemical relay station, the neuromuscular junction, where the nerve releases a messenger that tells the muscle to fire. In some diseases the wires and the muscle are both fine, but this handover is unreliable, like a relay where the baton is sometimes fumbled. The classic example is myasthenia gravis, where the body's own antibodies block the receivers on the muscle side, so muscles tire and weaken the more they are used, often showing up as drooping eyelids or double vision that worsen through the day.
Ordinary nerve conduction studies usually look normal here, so a special test is used: repetitive nerve stimulation. Instead of one shock, the examiner delivers a train of several shocks a second to a nerve and watches the size of the muscle response, the CMAP, change across the train. In myasthenia gravis the handover fails progressively, so each successive response is a little smaller than the last, a decrementing pattern that betrays a failing junction. A different disorder, where the nerve releases too little messenger to begin with, can show the opposite: tiny responses that grow larger after brief exercise or fast stimulation.
This is how electrodiagnosis tests the one station the routine study tends to miss, and it is decisive when weakness is fatigable and shifting rather than fixed. A clear decrement supports a neuromuscular junction disorder and steers the workup toward antibody tests and treatment that targets the junction, a completely different path from a nerve or muscle disease. The test has limits: it can be uncomfortable, mildly affected muscles may not show a decrement, and a normal result does not fully exclude the diagnosis, so it is read alongside the clinical picture and blood work.
A patient whose eyelids droop and whose voice fades by evening has normal routine nerve and needle studies, but when a facial or shoulder nerve is stimulated repeatedly, the CMAP shrinks step by step across the first few responses. That decrementing response supports a neuromuscular junction disorder such as myasthenia gravis and prompts antibody testing rather than a hunt for a damaged nerve.
A response that shrinks across the train betrays a failing neuromuscular junction.
A normal repetitive stimulation study does not rule out a neuromuscular junction disorder, especially a mild or purely eye-muscle one; more sensitive tests like single-fibre EMG and blood antibody tests may still be needed, so a negative result is reassuring but not final.